Company Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Shanghai S.E.

688505

CNE100004BN8

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
6.65 ^CNY	+1.84%		-7.64%	-27.95%

04-29	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-22	Shanghai Fudan-Zhangjiang Buys Structured Deposits Worth 200 Million Yuan	MT

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.

Number of employees: 948

HKD in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical Products 100.0 %	1,199	100.0 %	940	100.0 %	-21.60%

HKD in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	1,199	100.0 %	940	100.0 %	-21.60%

Managers	Title	Age	Since
Jun Li FOU	Founder	55	10/11/96
Da Jun Zhao FOU	Founder	54	10/11/96
Yan Xue DFI	Director of Finance/CFO	43	31/05/10
Dai Qing Yu BRD	Director/Board Member	51	31/10/01
Wen Bo Zhang AUD	Comptroller/Controller/Auditor	-	-

Members of the board	Title	Age	Since
Xiao Yang Yu BRD	Director/Board Member	68	29/05/13
Bo Shen BRD	Director/Board Member	51	28/06/12
Xiao Long Liu BRD	Director/Board Member	67	12/05/16
Da Jun Zhao FOU	Founder	54	10/11/96
Yan Xue DFI	Director of Finance/CFO	43	31/05/10
Ai Guo Zhou BRD	Director/Board Member	55	29/05/23
Dai Qing Yu BRD	Director/Board Member	51	31/10/01
Jian Huang CHM	Chairman	54	08/06/17
Hong Guang Wang BRD	Director/Board Member	-	-
Pei Long Xu BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	710,572,100	215,912,309 ( 30.39 %)	0	45.47 %
Stock B	1	326,000,000	255,386,000 ( 78.34 %)	0

Name	Equities	%	Valuation
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD 21.65 %	70,564,000	21.65 %	19 M ¥
Invesco Hong Kong Ltd. 4.957 %	16,160,000	4.957 %	4 M ¥
Yan Xue 0.0153 %	50,000	0.0153 %	13 809 ¥
DFA Australia Ltd. 0.004740 %	15,454	0.004740 %	4 268 ¥

Name	Equities	%	Valuation
China New Enterprise Investment Co., Ltd. 22.08 %	156,892,912	22.08 %	167 M ¥
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD 19.64 %	139,578,560	19.64 %	149 M ¥
Zong Meng Yang 11.26 %	80,000,000	11.26 %	85 M ¥
Hai Bo Wang 8.146 %	57,886,430	8.146 %	62 M ¥
Yong Su 2.629 %	18,677,860	2.629 %	20 M ¥
Da Jun Zhao 2.148 %	15,260,710	2.148 %	16 M ¥
Jun Li 1.269 %	9,018,200	1.269 %	10 M ¥
Shanghai Pudong Science & Technology Investment Co. Ltd. 0.9235 %	6,562,382	0.9235 %	7 M ¥
Gfund Management Co., Ltd. 0.5491 %	3,902,012	0.5491 %	4 M ¥
Yan Xue 0.2786 %	1,980,000	0.2786 %	2 M ¥

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

Zhangjiang Hi-Tech Park No. 308 Cailun Road

201210, Shanghai

http://www.fd-zj.com

address Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.(688505)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
MERCK KGAA	+18.88%	80.5B
KYOWA KIRIN CO. LTD.	+14.11%	9.15B
SK BIOPHARMACEUTICALS CO., LTD.	-14.14%	4.9B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43.39%	4.49B
YUHAN CORPORATION	+18.90%	4.44B
INDIVIOR PLC	+7.93%	2.19B
BETTA PHARMACEUTICALS CO., LTD.	-28.40%	2.13B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+15.93%	2.1B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-43.17%	1.78B

Specialty & Advanced Pharmaceuticals